These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 33166590)

  • 1. Multi-omics analysis of copy number variations of RNA regulatory genes in soft tissue sarcoma.
    Wang X; Han Y; Li J; Hong D; Xue Z; Huang H; Du Z; Hou Y; Li H; Li H; Liao H; Xie X; Ding C
    Life Sci; 2021 Jan; 265():118734. PubMed ID: 33166590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determining the prognostic significance of alternative splicing events in soft tissue sarcoma using data from The Cancer Genome Atlas.
    Yang X; Huang WT; He RQ; Ma J; Lin P; Xie ZC; Ma FC; Chen G
    J Transl Med; 2019 Aug; 17(1):283. PubMed ID: 31443718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and validation of prognostic markers in sarcomas base on a multi-omics analysis.
    Song Y; Yang K; Sun T; Tang R
    BMC Med Genomics; 2021 Jan; 14(1):31. PubMed ID: 33509178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integration of genomic copy number variations and chemotherapy-response biomarkers in pediatric sarcoma.
    Cheng L; Pandya PH; Liu E; Chandra P; Wang L; Murray ME; Carter J; Ferguson M; Saadatzadeh MR; Bijangi-Visheshsaraei K; Marshall M; Li L; Pollok KE; Renbarger JL
    BMC Med Genomics; 2019 Jan; 12(Suppl 1):23. PubMed ID: 30704460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Prognostic Molecular Signature of N⁶-Methyladenosine Methylation Regulators for Soft-Tissue Sarcoma from The Cancer Genome Atlas Database.
    Hou M; Guo X; Chen Y; Cong L; Pan C
    Med Sci Monit; 2020 Dec; 26():e928400. PubMed ID: 33370249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrated genomic and transcriptomic analysis revealed mutation patterns of de-differentiated liposarcoma and leiomyosarcoma.
    Liu W; Tong H; Zhang C; Zhuang R; Guo H; Lv C; Yang H; Lin Q; Guo X; Wang Z; Wang Y; Shen F; Wang S; Dai C; Wang G; Liu J; Lu W; Zhang Y; Zhou Y
    BMC Cancer; 2020 Oct; 20(1):1035. PubMed ID: 33115433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. m6A Modification Patterns With Distinct Immunity, Metabolism, and Stemness Characteristics in Soft Tissue Sarcoma.
    Huang ZD; Lin LL; Liu ZZ; Hu C; Gu HY; Wei RX
    Front Immunol; 2021; 12():765723. PubMed ID: 35003079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ovarian cancer subtypes based on the regulatory genes of RNA modifications: Novel prediction model of prognosis.
    Zheng P; Li N; Zhan X
    Front Endocrinol (Lausanne); 2022; 13():972341. PubMed ID: 36545327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations of cancer-related genes in soft tissue sarcomas: hypermethylation of RASSF1A is frequently detected in leiomyosarcoma and associated with poor prognosis in sarcoma.
    Seidel C; Bartel F; Rastetter M; Bluemke K; Wurl P; Taubert H; Dammann R
    Int J Cancer; 2005 Apr; 114(3):442-7. PubMed ID: 15551306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-Talk of Multiple Types of RNA Modification Regulators Uncovers the Tumor Microenvironment and Immune Infiltrates in Soft Tissue Sarcoma.
    Qi L; Zhang W; Ren X; Xu R; Yang Z; Chen R; Tu C; Li Z
    Front Immunol; 2022; 13():921223. PubMed ID: 35860263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T-cell infiltration and clonality correlate with programmed cell death protein 1 and programmed death-ligand 1 expression in patients with soft tissue sarcomas.
    Pollack SM; He Q; Yearley JH; Emerson R; Vignali M; Zhang Y; Redman MW; Baker KK; Cooper S; Donahue B; Loggers ET; Cranmer LD; Spraker MB; Seo YD; Pillarisetty VG; Ricciotti RW; Hoch BL; McClanahan TK; Murphy E; Blumenschein WM; Townson SM; Benzeno S; Riddell SR; Jones RL
    Cancer; 2017 Sep; 123(17):3291-3304. PubMed ID: 28463396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of PLAGL1-specific CpG site methylation in soft-tissue sarcomas.
    Peille AL; Brouste V; Kauffmann A; Lagarde P; Le Morvan V; Coindre JM; Chibon F; Bresson-Bepoldin L
    PLoS One; 2013; 8(11):e80741. PubMed ID: 24260468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The expression and clinical significance of UHRF1 in soft tissue sarcomas and its prognostic value.
    Shu Q; Liu X; Xiang X; Bo X
    Medicine (Baltimore); 2024 Jun; 103(23):e38393. PubMed ID: 38847665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas.
    ;
    Cell; 2017 Nov; 171(4):950-965.e28. PubMed ID: 29100075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic and prognostic gene expression signatures in 177 soft tissue sarcomas: hypoxia-induced transcription profile signifies metastatic potential.
    Francis P; Namløs HM; Müller C; Edén P; Fernebro J; Berner JM; Bjerkehagen B; Akerman M; Bendahl PO; Isinger A; Rydholm A; Myklebost O; Nilbert M
    BMC Genomics; 2007 Mar; 8():73. PubMed ID: 17359542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene Characteristics and Prognostic Values of m
    Li N; Chen X; Liu Y; Zhou T; Li W
    J Healthc Eng; 2021; 2021():2257066. PubMed ID: 34367534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Copy number variation analysis of m
    Wang X; Yu J; Chen J; Hou Y; Du Z; Huang H; Tang S; Han Y; Ding C; Xue Z
    Cancer Med; 2021 Nov; 10(21):7804-7815. PubMed ID: 34668652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The construction and analysis of tumor-infiltrating immune cell and ceRNA networks in recurrent soft tissue sarcoma.
    Huang R; Meng T; Chen R; Yan P; Zhang J; Hu P; Zhu X; Yin H; Song D; Huang Z
    Aging (Albany NY); 2019 Nov; 11(22):10116-10143. PubMed ID: 31739284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. m6A-related metabolism molecular classification with distinct prognosis and immunotherapy response in soft tissue sarcoma.
    Huang ZD; Fu YC; Liu SY; Mao YJ; Zhang Y; Hu C; Wei RX
    Front Immunol; 2022; 13():895465. PubMed ID: 35967408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular characterization of ferroptosis in soft tissue sarcoma constructs a prognostic and immunotherapeutic signature through experimental and bioinformatics analyses.
    Yang ZQ; Guo LY; Xiao KW; Zhang C; Wu MH; Yan FF; Cai L
    Aging (Albany NY); 2023 Oct; 15(20):11412-11447. PubMed ID: 37874682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.